iii.On the basis of previously described US data, adjuvant treatment should be considered in all LCNEC patients following resection.35 Choice of chemotherapy in this setting will require consensus, but may also be stratified according to Rb1 and p16 status. This evidence concerns the gene RB1 and large cell neuroendocrine carcinoma.